@GBarnesMD Yes! Our large cohort had similar findings https://t.co/jbN2aDmX4n Caution needed when interpreting analyses of non-randomized patients treated in routine practice. Patients who restarted anticoagulation may have had (likely had?) better progno
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
RT @TripPrimaryCare: New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoag…
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/GmHlT8hjnS
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/GmHlT8hjnS
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/qItSdXiPu6
New2Trip: Rates of rebleeding, thrombosis & mortality associated w/ resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/GmHlT8hjnS
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @RevistaMFSamfyc: Tasas de resangrado, trombosis y mortalidad asociadas con la reanudación de terapia anticoagulante tras sangrado relac…
Tasas de resangrado, trombosis y mortalidad asociadas con la reanudación de terapia anticoagulante tras sangrado relacionado con anticoagulantes https://t.co/jzj3lD8MTO PMID 33649169
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding - PubMed 抗凝固薬で出血のため入院した患者における治療再開は,血栓リスクや死亡リスクを有意に低下させるが出血リスクは増加 https://t.co/8foeYQq66h
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagula… https://t.co/jfNyvPvGaF
RT @pinacol: 【コホート研究】経口抗凝固薬(OAC)服用中に出血で入院した65歳以上の患者において、OACの再開は、血栓症および死亡率の減少、再出血率の増加と関連した。 #ペ読 https://t.co/mz4vnGVqKj
出血の種類や患者さんの状態にもよるだろうけど、基本的にはOACは再開した方がよさげ。
RT @MacDeptMed: Derek Little, James Douketis, Anne Holbrook, @DebSiegal et al. characterized prescribing patterns for oral anticoagulants O…
RT @MacDeptMed: Derek Little, James Douketis, Anne Holbrook, @DebSiegal et al. characterized prescribing patterns for oral anticoagulants O…
RT @MacDeptMed: Derek Little, James Douketis, Anne Holbrook, @DebSiegal et al. characterized prescribing patterns for oral anticoagulants O…
Derek Little, James Douketis, Anne Holbrook, @DebSiegal et al. characterized prescribing patterns for oral anticoagulants OACs and compared the rates of bleeding, thrombosis and mortality in patients who resumed an OAC with those who did not. https://t.co/
【コホート研究】経口抗凝固薬(OAC)服用中に出血で入院した65歳以上の患者において、OACの再開は、血栓症および死亡率の減少、再出血率の増加と関連した。 #ペ読 https://t.co/mz4vnGVqKj
OACの再開は、血栓発生率(調整HR 0.60、95%信頼区間[CI] 0.50~0.72)および死亡率(調整HR 0.54、95%CI 0.48~0.60)の低下と関連し、再出血の発生率(調整HR 1.88、95%CI 1.64~2.17)の増加と関連している https://t.co/ivKhBVKxwl
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RCTs are ongoing to conclusively determine whether people with atrial fibrillation who suffer a major bleed on oral anticoagulants should resume OAC (COI alert - I chair the DSMB of 1). In meantime, this study suggests there is benefit in restarting https:
RT @bhwords: Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulan…
Observational study fr @DebSiegal looking at rebleeding, thrombosis & mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding Highlights the uncertainty in this area & need for trials https://t.co/34S
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RT @ODPRN_Research: A new Derek Little @ICESOntario study found that among adults aged 66 years and above hospitalized for bleeding while r…
A new Derek Little @ICESOntario study found that among adults aged 66 years and above hospitalized for bleeding while receiving oral anticoagulants (OACs), resuming OACs led to a reduction in thrombosis + mortality but an increase in bleeding. https://t.co
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
RT @ThrombosisCan: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-re…
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding https://t.co/NzuXoFolbj
RT @GBarnesMD: Such important info. Too many clinicians make this decision without getting patient input. I think it's critical to share wi…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
@SevestreMarie @ClubVasculaire @lasfmv @ODPCMV
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @Office_j: 【出血後OAC再開で生存率は?/ CMAJ】 カナダ、OAC服用下で出血のため入院した66歳以上の6793例観察:63.3%が消化管出血。全体の57%が1年以内にOAC再開。中央値は46日。OAC再開で再出血の補正後HRは1.88 [95%CI 1…
【出血後OAC再開で生存率は?/ CMAJ】 カナダ、OAC服用下で出血のため入院した66歳以上の6793例観察:63.3%が消化管出血。全体の57%が1年以内にOAC再開。中央値は46日。OAC再開で再出血の補正後HRは1.88 [95%CI 1.64-2.17] も、死亡HRは0.54 [0.48-0.60]。 https://t.co/R10p49IEK3
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @GBarnesMD: Such important info. Too many clinicians make this decision without getting patient input. I think it's critical to share wi…
RT @GBarnesMD: Such important info. Too many clinicians make this decision without getting patient input. I think it's critical to share wi…
Such important info. Too many clinicians make this decision without getting patient input. I think it's critical to share with the patient what we know about risks & benefits of restarting anticoagulation after a bleed. Thanks to @DebSiegal for leading
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
RT @MarcCarrier1: Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but…
Great cohort study (senior authored by one of my faves, @DebSiegal) Highlights tightrope we walk when restarting anticoags after bleeding (GI, ICH, other), balancing rebleeds & thrombosis. https://t.co/lUWx2B57DK
Resuming oral anticoagulation (OAC) after OAC-related bleed is associated wit a reduction in thrombosis and mortality but an increase in re-bleeding. More studies are needed! https://t.co/k5uyFEIT9L @DebSiegal @ThrombosisCan @canvector
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
RT @canvector: Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rate…
Congratulations to @DebSiegal et al on the publication in CMAJ today presenting contemporary data from pts in Ontario: Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding